Skip to main content
logo
Zhengye Biotechnology Holding Limited (ZYBT)
NASDAQ: ZYBT · Real-Time Price · USD
0.6980
-0.0570 (-7.55%)
At close: Jul 17, 2026, 4:00 PM EDT
0.7550
+0.0570 (8.17%)
After-hours: Jul 17, 2026, 4:00 PM EDT

ZYBT Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-82.9713.4737.5155.7446.47
Depreciation & Amortization
25.8824.1623.9118.816.01
Other Adjustments
25.594.397.049.393.04
Change in Receivables
60.6712.5939.35-47.37-40.68
Changes in Inventories
6.25-5.88-12.9-12.33-12.34
Changes in Accounts Payable
-3.36-0.4-35.61-9.6717.63
Changes in Accrued Expenses
0.422.7-0.580.210.52
Changes in Income Taxes Payable
0.28-0.23-7.73.190.8
Changes in Unearned Revenue
1.27-0.4-0.720.321.4
Changes in Other Operating Activities
-20.7-9.35-2.12-0.94-1.04
Operating Cash Flow
13.3341.0548.1817.3431.81
Operating Cash Flow Growth
-67.52%-14.81%177.96%-45.50%-
Capital Expenditures
-1.01-13.59-7.4-27.33-19.06
Sale of Property, Plant & Equipment
-0.111.06-0.13
Purchases of Intangible Assets
-11.62-14.19-4.2--7.34
Purchases of Investments
---1.22--
Investing Cash Flow
-12.63-27.67-11.77-27.33-26.27
Long-Term Debt Issued
70.4790.1279.8699.8530
Long-Term Debt Repaid
-82.56-92.86-54.89-64.97-22
Net Long-Term Debt Issued (Repaid)
-12.09-2.7424.9734.888
Issuance of Common Stock
44.55----
Net Common Stock Issued (Repurchased)
44.55----
Common Dividends Paid
--16.02-39.45-21.43-11.05
Other Financing Activities
-0.15-3.37-4.5--
Financing Cash Flow
32.31-22.13-18.9813.46-3.05
Effect of Exchange Rate Changes on Cash and Cash Equivalents
-1.290.17---
Net Cash Flow
31.73-8.5817.443.462.49
Free Cash Flow
12.3327.4640.79-9.9912.75
Free Cash Flow Growth
-55.12%-32.68%---
FCF Margin
10.59%14.73%19.27%-3.84%5.95%
Free Cash Flow Per Share
0.260.600.89-0.220.28
Levered Free Cash Flow
-72.855.5813.3153.8658.39
Unlevered Free Cash Flow
-72.3612.39-4.5629.6649.79
SEC Filings: 10-K · 10-Q